Finance

Lilly is now selling $12.9 billion of GLP-1 drugs every three months and expects to sell even more

Eli Lilly said its tirzepatide franchise had another stellar quarter.

M
MarketWatch
April 30, 2026·1 min read
Lilly is now selling $12.9 billion of GLP-1 drugs every three months and expects to sell even more

Image: MarketWatch

Eli Lilly said its tirzepatide franchise had another stellar quarter.

Original article

Lilly is now selling $12.9 billion of GLP-1 drugs every three months and expects to sell even more

Published by MarketWatch

Read full article